We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMTG icon
1326
Claros Mortgage Trust
CMTG
$306M
$150K ﹤0.01%
+18,682
New +$159K
PACB icon
1327
Pacific Biosciences
PACB
$422M
$149K ﹤0.01%
108,680
+92,526
+573% +$187K
EC icon
1328
Ecopetrol
EC
$32.9B
$148K ﹤0.01%
13,228
+1,180
+10% +$14K
CERT icon
1329
Certara
CERT
$1.17B
$146K ﹤0.01%
+10,517
New +$173K
MQ icon
1330
Marqeta
MQ
$1.8B
$145K ﹤0.01%
+6,610
New +$146K
TAK icon
1331
Takeda Pharmaceutical
TAK
$55.1B
$144K ﹤0.01%
+11,111
New +$147K
HAPN
1332
Happen Inc
HAPN
$2.08B
$144K ﹤0.01%
+16,986
New +$145K
MCW
1333
DELISTED
Mister Car Wash
MCW
$143K ﹤0.01%
+20,017
New +$141K
DNUT icon
1334
Krispy Kreme
DNUT
$543M
$142K ﹤0.01%
13,175
-474
-3% -$5.88K
AZUL
1335
DELISTED
Azul
AZUL
$141K ﹤0.01%
35,208
+16,552
+89% +$97K
RXRX icon
1336
Recursion Pharmaceuticals
RXRX
$1.57B
$138K ﹤0.01%
18,363
-398
-2% -$3.47K
AMBP icon
1337
Ardagh Metal Packaging
AMBP
$2.86B
$135K ﹤0.01%
+39,568
New +$149K
AIV
1338
Aimco
AIV
$380M
$133K ﹤0.01%
16,066
-388
-2% -$3.13K
LCID icon
1339
Lucid Motors
LCID
$2.46B
$130K ﹤0.01%
4,998
-247
-5% -$6.59K
BLDP
1340
Ballard Power Systems
BLDP
$874M
$130K ﹤0.01%
57,646
+21,587
+60% +$61.4K
BRCC icon
1341
BRC Inc
BRCC
$126M
$128K ﹤0.01%
20,801
+4,072
+24% +$21.2K
CNH
1342
CNH Industrial
CNH
$13.8B
$124K ﹤0.01%
12,252
+2,209
+22% +$25K
AGRO icon
1343
Adecoagro
AGRO
$1.53B
$120K ﹤0.01%
+12,306
New +$127K
XRN
1344
Chiron Real Estate Inc
XRN
$544M
$117K ﹤0.01%
2,571
-58
-2% -$2.52K
ABEV icon
1345
Ambev
ABEV
$47.3B
$116K ﹤0.01%
56,582
+936
+2% +$2.13K
PTEN icon
1346
Patterson-UTI
PTEN
$3.87B
$115K ﹤0.01%
11,108
-4,718
-30% -$51.7K
ARRY icon
1347
Array Technologies
ARRY
$818M
$112K ﹤0.01%
10,900
-17,023
-61% -$216K
RDFN
1348
DELISTED
Redfin
RDFN
$111K ﹤0.01%
18,416
+8,345
+83% +$52.1K
JBLU icon
1349
JetBlue
JBLU
$1.96B
$110K ﹤0.01%
18,001
-13,778
-43% -$83K
UPWK icon
1350
Upwork
UPWK
$1.09B
$108K ﹤0.01%
10,017
-2,038
-17% -$23.1K

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.